Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018104718) TREATMENT OF NEUROLOGICAL DISEASES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/104718 International Application No.: PCT/GB2017/053655
Publication Date: 14.06.2018 International Filing Date: 04.12.2017
Chapter 2 Demand Filed: 02.10.2018
IPC:
A61K 38/22 (2006.01) ,A61K 38/26 (2006.01) ,C07K 14/605 (2006.01) ,C07K 14/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
26
Glucagons
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
575
Hormones
605
Glucagons
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Applicants:
LANCASTER UNIVERSITY BUSINESS ENTERPRISES LIMITED [GB/GB]; University House Bailrigg Lancaster Lancashire LA1 4YW, GB
Inventors:
HÖLSCHER, Christian; GB
Agent:
SECERNA LLP; The Catalyst Baird Lane, Heslington East York North Yorkshire YO10 5GA, GB
HØIBERG P/S; Adelgade 12 1304 Copenhagen K, DK
HØIBERG P/S; Adelgade 12 1304 Copenhagen K, DK
Priority Data:
1620611.205.12.2016GB
Title (EN) TREATMENT OF NEUROLOGICAL DISEASES
(FR) TRAITEMENT DE MALADIES NEUROLOGIQUES
Abstract:
(EN) Aspects and embodiments of the present invention relate to the treatment of neurological disorders such as for example, Alzheimer's disease and Parkinson's disease. Particularly, certain embodiments relate to GIP/GLP-1 co-agonist peptides for use in the treatment of these two neurological disorders. Also included in the present invention are inter alia pharmaceutical compositions comprising the GIP/GLP-1 co-agonist peptides, together with methods of treating such disorders as well as other subject matter.
(FR) Des aspects et des modes de réalisation de la présente invention concernent le traitement de troubles neurologiques tels que, par exemple, la maladie d'Alzheimer et la maladie de Parkinson. En particulier, certains modes de réalisation concernent des peptides co-agonistes de GIP/GLP-1 destinés à être utilisés dans le traitement de ces deux troubles neurologiques. La présente invention concerne également, entre autres, des compositions pharmaceutiques comprenant les peptides co-agonistes de GIP/GLP-1, conjointement avec des méthodes de traitement de tels troubles ainsi que d'autres objets.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)